Updating results

584 results

Sort: Relevance | Date

Rapid tests for Group A Streptococcal infections in people with a sore throat: diagnostics consultation

We are listening to your views on this diagnostics guidance. Comments close 07 August 2019.

Diagnostics guidance In consultation

Lower urinary tract symptoms in men: assessment and management: surveillance consultation

We are listening to your views on this NICE guideline. Comments close 07 August 2019.

Clinical guideline In consultation

Balloon dilation for eustachian tube dysfunction: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 20 September 2019.

Interventional procedures guidance In consultation

Balloon cryoablation for Barrett's oesophagus: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 20 September 2019.

Interventional procedures guidance In consultation

Balloon cryoablation for squamous dysplasia of the oesophagus: interventional procedure consultation

We are listening to your views on this interventional procedures guidance. Comments close 20 September 2019.

Interventional procedures guidance In consultation

Fetal alcohol spectrum disorder: topic engagement

We are listening to your views on this quality standard. Comments close 08 October 2019.

Quality standard In consultation

Safe prescribing and withdrawal management of prescribed drugs associated with dependence and withdrawal: draft scope consultation

We are listening to your views on this NICE guideline. Comments close 26 September 2019.

NICE guideline In consultation

Cerebral palsy in adults: quality standard consultation

We are listening to your views on this quality standard. Comments close 30 September 2019.

Quality standard In consultation

Neonatal parenteral nutrition: draft guidance consultation

We are listening to your views on this NICE guideline. Comments close 18 October 2019.

NICE guideline In consultation

Community pharmacies: promoting health and wellbeing: topic engagement

We are listening to your views on this quality standard. Comments close 02 October 2019.

Quality standard In consultation

Healthcare-associated infections: prevention and control: surveillance consultation

We are listening to your views on this NICE guideline. Comments close 20 September 2019.

Public health guideline In consultation

Violence and aggression: short-term management in mental health, health and community settings: surveillance consultation

We are listening to your views on this NICE guideline. Comments close 02 October 2019.

NICE guideline In consultation

Faltering growth: topic engagement

We are listening to your views on this quality standard. Comments close 02 October 2019.

Quality standard In consultation

Tinnitus: assessment and management: draft guidance consultation

We are listening to your views on this NICE guideline. Comments close 01 November 2019.

NICE guideline In consultation

Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management: call for evidence

We are listening to your views on this NICE guideline. Comments close 16 October 2019.

NICE guideline In consultation

Intrapartum care: women with existing medical conditions or obstetric complications and their babies: quality standard consultation

We are listening to your views on this quality standard. Comments close 23 September 2019.

Quality standard In consultation

Clostridium botulinum neurotoxin type A for treating chronic sialorrhoea [ID1150]

In development [GID-TA10296] Expected publication date: 09 October 2019

Technology appraisal guidance In development

Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations ID1054

In development [GID-HST10025] Expected publication date: 09 October 2019

Highly specialised technologies guidance In development

Decision making and mental capacity

In development [GID-NG10009] Expected publication date: 03 October 2018

NICE guideline In development

Vagus nerve stimulation for treatment-resistant depression

In development [GID-IPG10133] Expected publication date: TBC

Interventional procedures guidance In development

Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention

In development [GID-IPG10132] Expected publication date: TBC

Interventional procedures guidance In development

Minimally invasive radical hysterectomy for early stage cervical cancer

In development [GID-IPG10131] Expected publication date: TBC

Interventional procedures guidance In development

Functional electrical stimulation to improve muscle strength in non-neurological chronic conditions

In development [GID-IPG10135] Expected publication date: TBC

Interventional procedures guidance In development

Transcranial magnetic stimulation for obsessive-compulsive disorder

In development [GID-IPG10134] Expected publication date: TBC

Interventional procedures guidance In development

Crisaborole for treating mild to moderate atopic dermatitis in people aged 2 years and older (ID1195)

In development [GID-TA10435] Expected publication date: 03 June 2020

Technology appraisal guidance In development

Insertion of an artificial iris implant for aniridia

In development [GID-IPG10130] Expected publication date: TBC

Interventional procedures guidance In development

Deep brain stimulation for refractory epilepsy

In development [GID-IPG10129] Expected publication date: TBC

Interventional procedures guidance In development

Cyanoacrylate glue occlusion for varicose veins

In development [GID-IPG10128] Expected publication date: TBC

Interventional procedures guidance In development

Mirvetuximab soravtansine for previously treated platinum-resistant FR-alpha positive ovarian cancer [ID1527]

In development [GID-TA10483] Expected publication date: TBC

Technology appraisal guidance In development

PneuX for preventing ventilator-associated pneumonia in intensive care

In development [GID-MT528] Expected publication date: 11 March 2020

Medical technologies guidance In development

Encorafenib with binimetinib and cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancer

In development [GID-TA10479] Expected publication date: 22 July 2020

Technology appraisal guidance In development

Selinexor with low-dose dexamethasone for treating refractory multiple myeloma ID1535

In development [GID-TA10412] Expected publication date: 06 January 2021

Technology appraisal guidance In development

Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer ID1504

In development [GID-TA10400] Expected publication date: 11 December 2019

Technology appraisal guidance In development

Fedratinib for splenomegaly and symptoms in myelofibrosis [ID1501]

In development [GID-TA10406] Expected publication date: TBC

Technology appraisal guidance In development

PEGPH20 with nab-paclitaxel and gemcitabine for treating metastatic pancreatic cancer ID1502

In development [GID-TA10402] Expected publication date: TBC

Technology appraisal guidance In development

Carotuximab with pazopanib for treating advanced angiosarcoma ID1503

In development [GID-TA10401] Expected publication date: TBC

Technology appraisal guidance In development

KTE-C19 for previously treated B-precursor acute lymphoblastic leukaemia ID1494

In development [GID-TA10424] Expected publication date: TBC

Technology appraisal guidance In development

Durvalumab (Imfinzi) + Tremelimumab + standard chemotherapy for non-small cell lung cancer (NSCLC) lacking activating EGFR mutations and ALK fusions ID1538

In development [GID-TA10422] Expected publication date: TBC

Technology appraisal guidance In development

Pembrolizumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency ID1498

In development [GID-TA10420] Expected publication date: TBC

Technology appraisal guidance In development

Pembrolizumab in combination for untreated, locally advanced or metastatic, triple negative breast cancer ID1546

In development [GID-TA10417] Expected publication date: TBC

Technology appraisal guidance In development

Ivosidenib for treating relapsed or refractory IDH1-positive acute myeloid leukaemia ID1548

In development [GID-TA10416] Expected publication date: 02 December 2020

Technology appraisal guidance In development

Entrectinib for treating ROS1-positive locally advanced or metastatic non-small-cell lung cancer [ID1541]

In development [GID-TA10415] Expected publication date: 05 February 2020

Technology appraisal guidance In development

Pembrolizumab with chemotherapy for untreated extensive-stage small-cell lung cancer ID1509

In development [GID-TA10413] Expected publication date: TBC

Technology appraisal guidance In development

Rezum for treating benign prostatic hyperplasia

In development [GID-MT529] Expected publication date: 06 April 2020

Medical technologies guidance In development

Thyroid cancer: assessment and management

In development [GID-NG10150] Expected publication date: 09 March 2022

NICE guideline In development

Nintedanib for treating interstitial lung disease caused by systemic sclerosis (ID1420)

In development [GID-TA10427] Expected publication date: TBC

Technology appraisal guidance In development

Workplace health: long-term sickness absence and management

In development [GID-QS10114] Expected publication date: 13 January 2021

Quality standard In development

Internal air: health effects

In development [GID-QS10113] Expected publication date: 20 October 2020

Quality standard In development

Elective joint replacement

In development [GID-QS10090] Expected publication date: 13 January 2021

Quality standard In development